GE HealthCare Technologies Inc. $GEHC Shares Sold by Alliancebernstein L.P.

Alliancebernstein L.P. trimmed its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 16.8% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 4,303,149 shares of the company’s stock after selling 869,244 shares during the quarter. Alliancebernstein L.P. owned approximately 0.94% of GE HealthCare Technologies worth $323,166,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Empowered Funds LLC increased its stake in GE HealthCare Technologies by 6.1% in the 1st quarter. Empowered Funds LLC now owns 28,848 shares of the company’s stock worth $2,328,000 after purchasing an additional 1,665 shares in the last quarter. Acadian Asset Management LLC acquired a new position in GE HealthCare Technologies in the 1st quarter worth approximately $259,000. Vise Technologies Inc. acquired a new position in GE HealthCare Technologies in the 2nd quarter worth approximately $354,000. Mitsubishi UFJ Trust & Banking Corp grew its position in GE HealthCare Technologies by 4.2% during the 2nd quarter. Mitsubishi UFJ Trust & Banking Corp now owns 214,988 shares of the company’s stock worth $15,924,000 after purchasing an additional 8,569 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA grew its position in GE HealthCare Technologies by 5.0% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 1,373,141 shares of the company’s stock worth $101,709,000 after purchasing an additional 65,448 shares in the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the company. UBS Group lowered GE HealthCare Technologies from a “neutral” rating to a “sell” rating and increased their target price for the company from $73.00 to $77.00 in a report on Thursday, January 15th. Jefferies Financial Group lifted their price target on GE HealthCare Technologies from $95.00 to $105.00 and gave the company a “buy” rating in a report on Thursday, December 11th. Bank of America upped their price target on GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a research report on Monday, January 5th. Morgan Stanley increased their price objective on GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an “equal weight” rating in a research note on Wednesday, February 4th. Finally, BTIG Research raised their price objective on GE HealthCare Technologies from $87.00 to $91.00 and gave the stock a “buy” rating in a research report on Wednesday, February 4th. Seven research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, GE HealthCare Technologies currently has a consensus rating of “Hold” and an average target price of $92.17.

GE HealthCare Technologies Stock Up 0.6%

GEHC opened at $70.77 on Monday. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $89.77. The business has a 50-day moving average of $80.78 and a 200-day moving average of $78.54. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.37 and a quick ratio of 1.13. The company has a market capitalization of $32.25 billion, a PE ratio of 15.52, a price-to-earnings-growth ratio of 1.56 and a beta of 1.03.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, beating the consensus estimate of $1.40 by $0.04. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The business had revenue of $5.70 billion during the quarter, compared to analysts’ expectations of $5.60 billion. During the same quarter in the previous year, the business posted $1.45 EPS. The firm’s quarterly revenue was up 7.1% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Equities research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be given a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend is Thursday, April 2nd. GE HealthCare Technologies’s payout ratio is currently 3.07%.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.